# Impact of an Endoscopic Treatment of the Line Z on the Gastronomic Recurrence and the Gastro- Esophageal Reflux Disease in the Care of the Adenocarcinoma of Barrett's Oesophagus

> **NCT03278327** · NA · UNKNOWN · sponsor: **Institut Paoli-Calmettes** · enrollment: 30 (estimated)

## Conditions studied

- Barrett Esophagus Adenocarcinoma

## Interventions

- **PROCEDURE:** Complete endoscopic resection at Day 1 and months 2, 4, 6 8 and month 10.
- **DEVICE:** Endoscopic resection at month 2 and month 4

## Key facts

- **NCT ID:** NCT03278327
- **Lead sponsor:** Institut Paoli-Calmettes
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-27
- **Primary completion:** 2022-12
- **Final completion:** 2023-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03278327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03278327, "Impact of an Endoscopic Treatment of the Line Z on the Gastronomic Recurrence and the Gastro- Esophageal Reflux Disease in the Care of the Adenocarcinoma of Barrett's Oesophagus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03278327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*